Jagomae T, Velling S, Tikva T, Maksimtsuk V, Gaur N, Reimets R
Diabetol Metab Syndr. 2025; 17(1):82.
PMID: 40050934
PMC: 11887366.
DOI: 10.1186/s13098-025-01651-6.
Duta C, Muscurel C, Dogaru C, Stoian I
Int J Mol Sci. 2025; 26(4).
PMID: 40003982
PMC: 11855881.
DOI: 10.3390/ijms26041516.
Movahednasab M, Dianat-Moghadam H, Khodadad S, Nedaeinia R, Safabakhsh S, Ferns G
Diabetol Metab Syndr. 2025; 17(1):60.
PMID: 39962520
PMC: 11834518.
DOI: 10.1186/s13098-025-01623-w.
Lin H, Yu I, Cheng M, Chang T, Lin H, Chang Y
Nat Commun. 2024; 15(1):10537.
PMID: 39627229
PMC: 11615295.
DOI: 10.1038/s41467-024-54927-2.
Pan Y, Li J, Fan Z, Chen Y, Huang X, Wu D
Microorganisms. 2024; 12(9).
PMID: 39338435
PMC: 11434092.
DOI: 10.3390/microorganisms12091760.
Semaglutide for the management of diabesity: The real-world experience.
Alkhalifah M, Afsar H, Shams A, Blaibel D, Chandrabalan V, Pappachan J
World J Methodol. 2024; 14(3):91832.
PMID: 39310241
PMC: 11230069.
DOI: 10.5662/wjm.v14.i3.91832.
Endoplasmic Reticulum Stress and Obesity.
Yilmaz E
Adv Exp Med Biol. 2024; 1460:373-390.
PMID: 39287859
DOI: 10.1007/978-3-031-63657-8_13.
Cardiovascular Protective Properties of GLP-1 Receptor Agonists: More than Just Diabetic and Weight Loss Drugs.
Le R, Nguyen M, Allahwala M, Psaltis J, Marathe C, Marathe J
J Clin Med. 2024; 13(16).
PMID: 39200816
PMC: 11355214.
DOI: 10.3390/jcm13164674.
Receptors and Signaling Pathways Controlling Beta-Cell Function and Survival as Targets for Anti-Diabetic Therapeutic Strategies.
Dalle S, Abderrahmani A
Cells. 2024; 13(15.
PMID: 39120275
PMC: 11311556.
DOI: 10.3390/cells13151244.
Wolfram Syndrome Type I Case Report and Review-Focus on Early Diagnosis and Genetic Variants.
Jurca A, Galea-Holhos L, Jurca A, Atasie D, Petchesi C, Severin E
Medicina (Kaunas). 2024; 60(7).
PMID: 39064493
PMC: 11278941.
DOI: 10.3390/medicina60071064.
Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus.
Abiola J, Oluyemi A, Idowu O, Oyinloye O, Ubah C, Owolabi O
Pharmaceuticals (Basel). 2024; 17(6).
PMID: 38931402
PMC: 11206448.
DOI: 10.3390/ph17060736.
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic Islets.
Reed J, Bain S, Kanamarlapudi V
Diabetes Metab Syndr Obes. 2024; 17:2419-2456.
PMID: 38894706
PMC: 11184168.
DOI: 10.2147/DMSO.S415934.
Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes.
Moon J, Choe H, Lim S
J Diabetes Investig. 2024; 15(6):669-683.
PMID: 38676410
PMC: 11143426.
DOI: 10.1111/jdi.14221.
A Comprehensive Review on GLP-1 Signaling Pathways in the Management of Diabetes Mellitus - Focus on the Potential Role of GLP-1 Receptors Agonists and Selenium among Various Organ Systems.
Barakat G, Assi G, Khalil H, Khatib S
Curr Diabetes Rev. 2024; 21(2):e160424228945.
PMID: 38629376
DOI: 10.2174/0115733998287178240403055901.
Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management.
Son J, Lim S
Endocrinol Metab (Seoul). 2024; 39(2):206-221.
PMID: 38626909
PMC: 11066441.
DOI: 10.3803/EnM.2024.1940.
From classical dualistic antagonism to hormone synergy: potential of overlapping action of glucagon, insulin and GLP-1 for the treatment of diabesity.
Kistkins S, Moser O, Ankudovics V, Bliznuks D, Mihailovs T, Lobanovs S
Endocr Connect. 2024; 13(5).
PMID: 38579770
PMC: 11046332.
DOI: 10.1530/EC-23-0529.
Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment.
Chen S, Wang X, Jin Y, Chen X, Song Q, Wei G
Diabetes Metab Syndr Obes. 2024; 17:1301-1308.
PMID: 38505539
PMC: 10949166.
DOI: 10.2147/DMSO.S443631.
Role of β-cell autophagy in β-cell physiology and the development of diabetes.
Yasasilka X, Lee M
J Diabetes Investig. 2024; 15(6):656-668.
PMID: 38470018
PMC: 11143416.
DOI: 10.1111/jdi.14184.
Olanzapine's effects on hypothalamic transcriptomics and kinase activity.
Pereira S, Castellani L, Kowalchuk C, Alganem K, Zhang X, Ryan W
Psychoneuroendocrinology. 2024; 163:106987.
PMID: 38340539
PMC: 10947847.
DOI: 10.1016/j.psyneuen.2024.106987.
Exendin-4 affects calcium signalling predominantly during activation and activity of beta cell networks in acute mouse pancreas tissue slices.
Leitgeb E, Kercmar J, Krizancic Bombek L, Pohorec V, Klemen M, Rupnik M
Front Endocrinol (Lausanne). 2024; 14:1315520.
PMID: 38292770
PMC: 10826511.
DOI: 10.3389/fendo.2023.1315520.